Femasys Management
Management criteria checks 2/4
Femasys' CEO is Kathy Lee-Sepsick, appointed in Feb 2004, has a tenure of 20.92 years. total yearly compensation is $1.02M, comprised of 49% salary and 51% bonuses, including company stock and options. directly owns 1.53% of the company’s shares, worth $416.50K. The average tenure of the management team and the board of directors is 2.3 years and 9.3 years respectively.
Key information
Kathy Lee-Sepsick
Chief executive officer
US$1.0m
Total compensation
| CEO salary percentage | 49.0% |
| CEO tenure | 20.9yrs |
| CEO ownership | 1.5% |
| Management average tenure | 2.3yrs |
| Board average tenure | 9.3yrs |
Recent management updates
Recent updates
Femasys (NASDAQ:FEMY) Has Debt But No Earnings; Should You Worry?
Oct 31
Shareholders May Be More Conservative With Femasys Inc.'s (NASDAQ:FEMY) CEO Compensation For Now
Jul 05Health Check: How Prudently Does Femasys (NASDAQ:FEMY) Use Debt?
Apr 03Here's Why We're Watching Femasys' (NASDAQ:FEMY) Cash Burn Situation
Sep 27Femasys commercially launches Femcerv for cervical cancer screening
Sep 29Femasys GAAP EPS of -$0.22 beats by $0.01, revenue of $0.3M misses by $0.01M
Aug 10We Think Femasys (NASDAQ:FEMY) Needs To Drive Business Growth Carefully
May 22Femasys: Revolutionizing Female Reproduction
Jul 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$18m |
| Jun 30 2024 | n/a | n/a | -US$17m |
| Mar 31 2024 | n/a | n/a | -US$15m |
| Dec 31 2023 | US$1m | US$500k | -US$14m |
| Sep 30 2023 | n/a | n/a | -US$13m |
| Jun 30 2023 | n/a | n/a | -US$12m |
| Mar 31 2023 | n/a | n/a | -US$11m |
| Dec 31 2022 | US$659k | US$423k | -US$11m |
| Sep 30 2022 | n/a | n/a | -US$11m |
| Jun 30 2022 | n/a | n/a | -US$10m |
| Mar 31 2022 | n/a | n/a | -US$9m |
| Dec 31 2021 | US$567k | US$540k | -US$8m |
| Sep 30 2021 | n/a | n/a | -US$7m |
| Jun 30 2021 | n/a | n/a | -US$6m |
| Mar 31 2021 | n/a | n/a | -US$7m |
| Dec 31 2020 | US$307k | US$280k | -US$7m |
Compensation vs Market: Kathy's total compensation ($USD1.02M) is above average for companies of similar size in the US market ($USD640.07K).
Compensation vs Earnings: Kathy's compensation has increased whilst the company is unprofitable.
CEO
Kathy Lee-Sepsick (56 yo)
20.9yrs
Tenure
US$1,019,425
Compensation
Ms. Kathy Lee-Sepsick M.B.A, is Founder of Femasys Inc. and has been its Chief Executive Officer and President since February 2004. She served as Chairman of Board of Femasys Inc. since February 2004 until...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 20.9yrs | US$1.02m | 1.53% $ 416.5k | |
| Chief Financial Officer | 2.9yrs | US$716.22k | 0% $ 0 | |
| COO, Senior VP & Secretary | 21yrs | US$630.42k | 0.39% $ 106.7k | |
| Vice President of Counsel & Intellectual Property | no data | no data | no data | |
| Vice President of Marketing | no data | no data | no data | |
| Vice President of Sales | 1yr | no data | no data | |
| Chief Medical Advisor | no data | no data | no data | |
| Senior VP of Regulatory & Clinical Affairs | 2.3yrs | no data | no data | |
| Chief Medical Officer | 1.2yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data |
2.3yrs
Average Tenure
56yo
Average Age
Experienced Management: FEMY's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 20.9yrs | US$1.02m | 1.53% $ 416.5k | |
| Independent Non-Executive Chairman of Board | 9.3yrs | US$108.93k | 0.14% $ 37.5k | |
| Independent Director | 1.2yrs | US$5.00k | no data | |
| Independent Director | 19.4yrs | US$41.97k | 5.32% $ 1.4m | |
| Independent Director | 1.6yrs | US$31.44k | 0.025% $ 6.7k |
9.3yrs
Average Tenure
56yo
Average Age
Experienced Board: FEMY's board of directors are considered experienced (9.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 00:34 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Femasys Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Keay Nakae | Chardan Capital Markets, LLC |
| Emily Bodnar | H.C. Wainwright & Co. |
| Catherine Novack | JonesTrading Institutional Services, LLC |